Nov 16, 2021
Onward Chairman and CEO, Grace Yeh, awarded ITRI laureate for lifetime achievement in Taiwan
We are very pleased to announce that, Grace Yeh, our Chairman and CEO, has received a prestigious award from the Industrial Technology Research Institute (ITRI) in Taiwan for her lifetime achievement as a business leader. Under Grace’s leadership, Onivyde® was the first cancer drug developed in Taiwan to be approved by the US FDA in 2015.
Taiwan’s President Tsai Ing-wen presented the award personally to Grace, who is the first female business leader to become a laureate.
More details on the ITRI website / on Focus Taiwan
ITRI it is a not-profit R&D organization engaging in applied research and technical services. Founded in 1973, ITRI has played a vital role in transforming Taiwan's economy from a labor-intensive industry to a high-tech industry.